Skip to main content
IMNM logo

Immunome, Inc.

IMNMNASDAQHealthcareBiotechnology

$17.89Today:- (-)1Y +13.70%

As of Oct 26, 2026 close

Market cap
$2.03B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$14.64$30.06
Volume (live)
-
Avg. volume (3M)
1.54M

Immunome, Inc. (IMNM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Immunome, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(16 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$35.33
+97.48% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest IMNM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Sharon Zackfia
William Blair
BuyInitiates
$35.00
Dara Azar
Stifel Nicolaus
HoldMaintains
$24.00
Charles Zhu
LifeSci Capital
BuyMaintains
$40.00
Lukas Shumway
Barclays
BuyMaintains
$36.00
Dara Azar
Stifel Nicolaus
HoldInitiates
$24.00
Matthew Venezia
Alliance Global Partners
BuyInitiates
$32.00
Andres Y. Maldonado
HC Wainwright
BuyReiterates
$40.00
Andres Y. Maldonado
HC Wainwright
BuyReiterates
$40.00
Michael Schmidt
Guggenheim
BuyMaintains
$35.00
Adam Vogel
Craig-Hallum
BuyMaintains
$36.00
Unknown Analyst
Wedbush
BuyMaintains
$31.00 → $35.00
Michael Schmidt
Guggenheim
BuyMaintains
$35.00
Biren Amin
Piper Sandler
BuyMaintains
$33.00
Supawat Thongthip
Truist
BuyMaintains
$37.00 → $38.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$40.00
Tyler Van Buren
TD Cowen
BuyMaintains
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IMNM?

The analyst consensus rating for IMNM is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for IMNM?

The average 12-month price target for IMNM is $35.33, representing an upside of 97.5% from the Oct 26, 2026 close of $17.89.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.